SRTS · Sensus Healthcare, Inc. · Executive Compensation
$2.36
+0.06 (+2.61%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$38.85M
Shares
16.46M
Volume · Nov 19
170.43K
Avg daily vol (3M)
205.66K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $1,417,860 |
| Michael Sardano | President, General Counsel, Chief Commercial Officer, & Corporate Secretary | $1,213,917 |
| Javier Rampolla | Chief Financial Officer | $752,710 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Michael Sardano | President, General Counsel, & Corporate Secretary | $1,275,078 |
| Joseph Sardano | Chief Executive Officer | $1,268,030 |
| Javier Rampolla | Chief Financial Officer | $656,045 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $687,599 |
| Michael Sardano | President, General Counsel, & Corporate Secretary | $452,523 |
| Javier Rampolla | Chief Financial Officer | $357,062 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $754,428 |
| Javier Rampolla | Chief Financial Officer | $439,144 |
| Michael Sardano | President, General Counsel, & Corporate Secretary | $404,739 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $628,451 |
| Javier Rampolla | Chief Financial Officer | $430,732 |
| Michael Sardano | President, General Counsel, & Corporate Secretary | $426,973 |
| Stephen Cohen | Executive VP, Strategic Initiatives and Dermatology Sales | $409,382 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joseph Sardano | Chief Executive Officer | $510,006 |
| Stephen Cohen | Executive VP, Strategic Initiatives and Dermatology Sales | $435,737 |
| Michael Sardano | Vice President & General Counsel | $261,072 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Stephen Cohen | Executive VP, Strategic Initiatives and Dermatology Sales | $521,260 |
| Joseph Sardano | Chief Executive Officer | $466,800 |
| Arthur Levine | Chief Financial Officer | $284,448 |
| Michael Sardano | Vice President & General Counsel | $228,859 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Arthur Levine | Chief Financial Officer | $584,600 |
| Joseph Sardano | Chief Executive Officer | $538,392 |
| Stephen Cohen | Executive VP, Strategic Initiatives and Dermatology Sales | $478,617 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Larry Biscotti | Class I director | Appointed | 2026-01-12 |
| Eric Sachetta | Class II director | Appointed | 2025-11-13 |
|
Dr. John Heinrich
“To the knowledge of the Company’s executive officers, Dr. Heinrich’s decision to resign was not the result of any disagreement between Dr. Heinrich and the Registrant that would require disclosure under Item 5.02(a) of Form 8-K.”
|
director | Resigned | 2024-05-31 |
|
Samuel O'Rear
“Mr. O’Rear’s decision to retire was not the result of any disagreement between Mr. O’Rear and the Company that would require disclosure under Item 5.02(a) of Form 8-K.”
|
director | Retired | 2024-02-02 |
| Michael Sardano | director | Appointed | 2024-01-18 |
| Javier Rampolla | Chief Financial Officer | Appointed | 2023-06-06 |
| Magdalena Martinez | Chief Operating Officer | Appointed | 2023-01-09 |
| Stephen Cohen | Executive Vice President, Strategic Initiatives and Dermatology | Resigned | 2022-01-31 |
| Joseph C. Sardano | President | Resigned | 2022-01-31 |
| Michael J. Sardano | President | Appointed | 2022-01-31 |
Leadership
- Joseph Sardano CEO
- Arthur Levine CFO
- Javier Rampolla CFO
- Magdalena Martinez COO
- Carlton Chow CTO
- Michael Sardano General Counsel, Board Member
- Eric Sachetta Board Member
- Larry Biscotti Board Member
- Megan Cornish Board Member
Key facts
CIK
1494891
CUSIP
81728J109
13F (30d)
42 filings
36 filers
Visit website
Investor relations